Thursday, May 16, 2024
Facebook Linkedin Twitter
HomeIndustriesBiotechnology

Biotechnology

Biotechnology

Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results

PR Newswire -
The Janssen Pharmaceutical Companies of Johnson & Johnson announced new analyses from the Phase 3 MAIA study of DARZALEX in combination with lenalidomide and...
Biotechnology

RemeGen’s RC118 for Injection Targeting Claudin 18.2 in Patients with Gastric and Pancreatic Cancers Granted Two Orphan Drug Designations by U.S. FDA

PR Newswire -
RemeGen Co., Ltd. , a commercial-stage biotechnology company, announced on December 7, 2022, that its latest antibody-drug conjugate (ADC), RC118 for injection, has been granted...
Biotechnology

Body of Evidence Grows From ZUMA-7 Study Supporting Initial Treatment

Business Wire -
Kite, a Gilead Company announced findings from two new analyses of the landmark ZUMA-7 trial of Yescarta, the largest and longest follow-up of a...
Biotechnology

Ajax Therapeutics Presents Preclinical Data on AJ1-10502, a Type II JAK2 Inhibitor

Business Wire -
Ajax Therapeutics, Inc., a biopharmaceutical company applying computational chemistry and structure-based technologies to develop novel, selective small molecules for myeloproliferative neoplasms (MPNs), announced the...
Biotechnology

Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286

Business Wire -
Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the U.S., Europe, and additional international markets, announced...
1...838485...235Page 84 of 235
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us